Cargando…
Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance
Drug resistance is a commonly unavoidable consequence of cancer treatment that results in therapy failure and disease relapse. Intrinsic (pre-existing) or acquired resistance mechanisms can be drug-specific or be applicable to multiple drugs, resulting in multidrug resistance. The presence of drug r...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912423/ https://www.ncbi.nlm.nih.gov/pubmed/33525637 http://dx.doi.org/10.3390/cells10020260 |
_version_ | 1783656574338727936 |
---|---|
author | Cetin, Ronay Quandt, Eva Kaulich, Manuel |
author_facet | Cetin, Ronay Quandt, Eva Kaulich, Manuel |
author_sort | Cetin, Ronay |
collection | PubMed |
description | Drug resistance is a commonly unavoidable consequence of cancer treatment that results in therapy failure and disease relapse. Intrinsic (pre-existing) or acquired resistance mechanisms can be drug-specific or be applicable to multiple drugs, resulting in multidrug resistance. The presence of drug resistance is, however, tightly coupled to changes in cellular homeostasis, which can lead to resistance-coupled vulnerabilities. Unbiased gene perturbations through RNAi and CRISPR technologies are invaluable tools to establish genotype-to-phenotype relationships at the genome scale. Moreover, their application to cancer cell lines can uncover new vulnerabilities that are associated with resistance mechanisms. Here, we discuss targeted and unbiased RNAi and CRISPR efforts in the discovery of drug resistance mechanisms by focusing on first-in-line chemotherapy and their enforced vulnerabilities, and we present a view forward on which measures should be taken to accelerate their clinical translation. |
format | Online Article Text |
id | pubmed-7912423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79124232021-02-28 Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance Cetin, Ronay Quandt, Eva Kaulich, Manuel Cells Review Drug resistance is a commonly unavoidable consequence of cancer treatment that results in therapy failure and disease relapse. Intrinsic (pre-existing) or acquired resistance mechanisms can be drug-specific or be applicable to multiple drugs, resulting in multidrug resistance. The presence of drug resistance is, however, tightly coupled to changes in cellular homeostasis, which can lead to resistance-coupled vulnerabilities. Unbiased gene perturbations through RNAi and CRISPR technologies are invaluable tools to establish genotype-to-phenotype relationships at the genome scale. Moreover, their application to cancer cell lines can uncover new vulnerabilities that are associated with resistance mechanisms. Here, we discuss targeted and unbiased RNAi and CRISPR efforts in the discovery of drug resistance mechanisms by focusing on first-in-line chemotherapy and their enforced vulnerabilities, and we present a view forward on which measures should be taken to accelerate their clinical translation. MDPI 2021-01-28 /pmc/articles/PMC7912423/ /pubmed/33525637 http://dx.doi.org/10.3390/cells10020260 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cetin, Ronay Quandt, Eva Kaulich, Manuel Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance |
title | Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance |
title_full | Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance |
title_fullStr | Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance |
title_full_unstemmed | Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance |
title_short | Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance |
title_sort | functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912423/ https://www.ncbi.nlm.nih.gov/pubmed/33525637 http://dx.doi.org/10.3390/cells10020260 |
work_keys_str_mv | AT cetinronay functionalgenomicsapproachestoelucidatevulnerabilitiesofintrinsicandacquiredchemotherapyresistance AT quandteva functionalgenomicsapproachestoelucidatevulnerabilitiesofintrinsicandacquiredchemotherapyresistance AT kaulichmanuel functionalgenomicsapproachestoelucidatevulnerabilitiesofintrinsicandacquiredchemotherapyresistance |